- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07496268
The Effect of Art-based Mandala Intervention (mandala)
The Effect of Art-based Mandala Intervention on Death Anxiety and Anger Levels in Elderly Adults Living in Nursing Homes: A Randomized Controlled Study
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.
Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Objective This study aimed to investigate the effect of art-based mandala intervention on anger and death anxiety in older adults residing in a nursing home.
Methods A randomized controlled experimental study with 80 participants (experimental group n = 40; control group n = 40) was conducted. The experimental group participated in mandala coloring three times a week for 12 weeks. Data were collected using a descriptive form, a death anxiety scale, and the State-Trait Anger Expression Inventory.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Kartal
-
Istanbul, Kartal, Turkey (Türkiye), 34862
- Istanbul Medeniyet University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- residing in the nursing home, being 65 years of age or older, scoring 24 or more points on the Mini-Mental State Examination, having no psychiatric diagnoses, not currently participating in courses related to coping with anxiety and stress, and voluntarily agreeing to participate in the study.
Exclusion Criteria:
- out of the inclusion criteria
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Mandala
|
Mnadala coloring
|
|
Other: Control
do nothing
|
do nothing
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Death Anxiety Scale
Time Frame: Baseline and 12 weeks follow-up
|
Death Anxiety Scale: The validity and reliability study of the Turkish version of the "Death Anxiety Scale".
The scale 15-item true/false scale measures anxiety and fear related to one's own death and mortality risk.
Each "yes" response to the first nine items and each "no" response to the remaining six items receives a score of "1."
The total score indicates the level of death anxiety.
The maximum possible score is 15, with scores interpreted as follows: 0-4 (mild), 5-9 (moderate), 10-14 (severe), and 15 (panic).
|
Baseline and 12 weeks follow-up
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ıstanbulımu IMU-2026-BD
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.